HEALTH

K-V establishes generic drug subsidiary Nesher Pharmaceuticals

BY Alaric DeArment

ST. LOUIS K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said Wednesday.

 

K-V announced the establishment of Nesher Pharmaceuticals, appointing as its president Mark Hartman, who has had several positions in generic drug companies.

 

 

“Mark brings recognized depth and breadth of generic industry experience and leadership to K-V,” K-V interim president and CEO Greg Divis said. “We are excited to have Mark join our organization and look forward to him leading the introduction of Nesher Pharmaceuticals Inc., K-V’s new generic subsidiary.”

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Cardiovascular, diabetes risk associated with prostate cancer drug class

BY Alaric DeArment

SILVER SPRING, Md. Patients taking a certain class of drugs mostly used for prostate cancer may be at higher risk of heart disease and diabetes, the Food and Drug Administration warned on Wednesday.

 

The FDA said it would require manufacturers to add new warnings to gonadotropin-releasing hormone agonists. GnRH agonists suppress the production of testosterone and are used in androgen-deprivation therapy in men with prostate cancer. Some of the drugs also are used to treat women with endometriosis and children with precocious puberty. GnRH agonists include Abbott’s Lupron (leuprolide acetate), Sanofi-Aventis’ Eligard (leuprolide acetate), Watson Pharmaceuticals’ Trelstar (triptorelin pamoate) and several other branded and generic drugs.

 

 

The agency said in May that analyses had found that patients taking GnRH agonists had a small increased risk for diabetes, heart attack, stroke and sudden death.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Good Neighbor Pharmacy donates funds to pharmacy schools

BY Alaric DeArment

VALLEY FORGE, Pa. AmerisourceBergen and its community pharmacy network program, Good Neighbor Pharmacy, will fund several education and scholarship programs for pharmacy students, the company said Wednesday.

AmerisourceBergen said the funding, pledged over the last few weeks, brought the total amount of money given to support the programs to more than $2 million.

“AmerisourceBergen is committed to supporting the practice of community pharmacy,” president and CEO Dave Yost said. “Community-based pharmacists are critical members of the evolving U.S. healthcare system and the most accessible professional of the patient’s healthcare team. We are pleased to encourage students to consider community pharmacy and retail entrepreneurship, and to continue this tradition of supportive care.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?